东睦股份重大资产重组审核恢复：拟收购上海富驰34.75%股权
关键要点梳理
- 东睦新材料集团股份有限公司（股票代码：600114，简称“东睦股份”）计划通过发行股份及支付现金方式，向五名交易对方收购上海富驰高科技股份有限公司（简称“上海富驰”）34.75%股权。
- 交易对方包括钟伟、上海创精投资咨询合伙企业（有限合伙）、宁波华莞企业管理合伙企业（有限合伙）、宁波富精企业管理合伙企业（有限合伙）、深圳市远致星火私募股权投资基金合伙企业（有限合伙）。
- 该项交易属于重大资产重组，并涉及募集配套资金及关联交易。
- 因财务资料过期，2026年3月31日上海证券交易所中止审核该交易。东睦股份及中介机构已完成财务数据更新和加期审计，已于2026年4月20日获得上交所恢复审核通知。
- 该交易还需获得上交所审核通过及中国证监会注册同意，能否获批以及最终时间均存在不确定性。
- 公司承诺将根据交易进展及时披露信息，提醒投资者注意投资风险。
对股东及投资者的重要影响
- 资产重组进展： 此次收购上海富驰34.75%股权将显著提升东睦股份的业务布局和产业规模，若顺利实施，可能对公司未来业绩、盈利能力产生积极影响，属于价格敏感信息。
- 审核与注册风险： 交易尚需监管部门审核和注册，存在无法获批或延迟实施的风险。投资者需关注后续进展，避免因政策变化导致投资决策失误。
- 信息披露义务： 公司承诺严格按照规定及时披露信息，投资者应密切关注公司公告，及时掌握交易动态。
- 关联交易与配套融资： 此次交易涉及关联方及配套融资安排，可能影响公司资本结构及财务状况，需投资者重点关注。
详细解读
东睦股份此次披露重大资产重组最新进展，显示公司已完成必要的财务资料补充和审计工作，获得上交所恢复审核。这意味着公司并未放弃对上海富驰的收购计划，并且已积极推进相关手续。收购上海富驰34.75%股权，若顺利完成，将增强东睦股份在新材料领域的竞争力和市场份额，可能成为公司未来业绩增长的驱动力。
由于交易涉及发行股份与现金支付，且属于关联交易，投资者需关注交易对公司股本结构和现有股东权益的影响。此外，交易尚需上交所及证监会的最终审批，存在一定不确定性。公司已承诺将根据交易进展及时披露信息，提醒投资者关注后续动态，防范相关风险。
此次公告属于重大资产重组进展的核心信息，具有较强的价格敏感性，可能影响东睦股份的股价表现，建议投资者密切关注。
免责声明：
本文仅为信息解读，不构成任何投资建议。投资者应根据自身风险偏好及公告原文，谨慎决策。公司相关交易仍存不确定性，请投资者注意相关风险。
English Version
Key Points Summary
- NBMT New Materials Group Co., Ltd. (Stock Code: 600114, “NBTM”) plans to acquire a 34.75% stake in Shanghai Fuchi High-Tech Co., Ltd. (“Shanghai Fuchi”) from five counterparties by issuing shares and paying cash.
- The transaction counterparties include Zhong Wei, Shanghai Chuangjing Investment Consulting Partnership (Limited Partnership), Ningbo Huaguan Enterprise Management Partnership (Limited Partnership), Ningbo Fujing Enterprise Management Partnership (Limited Partnership), and Shenzhen Yuanzhi Xinghuo Private Equity Investment Fund Partnership (Limited Partnership).
- This deal is a major asset restructuring, involving supporting fund raising and related-party transactions.
- Due to outdated financial information, the Shanghai Stock Exchange suspended its review of the transaction on March 31, 2026. After NBTM and intermediaries completed updated financial data and extended audits, the review was resumed on April 20, 2026.
- The transaction still needs approval from the Shanghai Stock Exchange and registration by the China Securities Regulatory Commission. There is uncertainty regarding whether and when approval will be obtained.
- The company promises to disclose information in a timely manner as the transaction progresses, reminding investors to pay attention to investment risks.
Important Information for Shareholders
- Asset Restructuring Progress: The acquisition of a 34.75% stake in Shanghai Fuchi will significantly improve NBTM’s business layout and industry scale. If implemented, this could positively impact future performance and profitability—a price-sensitive event.
- Audit and Registration Risks: The transaction is subject to regulatory review and registration. Investors should be aware of risks related to failure or delays in approval.
- Disclosure Obligations: The company pledges to disclose information promptly. Investors should closely monitor announcements for updates.
- Related-Party Transactions & Fund Raising: The deal involves related parties and supporting fund raising, which may affect the capital structure and financial status of the company.
Analysis
NBTM has completed the necessary financial supplement and audit work and has received approval to resume review by the Shanghai Stock Exchange. This signals continued pursuit of the Shanghai Fuchi acquisition. If successful, it will enhance NBTM’s competitiveness and market share in advanced materials, potentially driving future earnings growth.
Since the deal involves both share issuance and cash payment, and is a related-party transaction, investors must consider its impact on shareholding structure and shareholder rights. The deal is subject to regulatory approval and uncertainty remains. The company has pledged to disclose information promptly and investors are advised to follow the developments closely.
This announcement is a core update on major asset restructuring, is highly price-sensitive, and may affect NBTM’s share price. Investors are advised to pay close attention.
Disclaimer:
This article is for informational purposes only and does not constitute investment advice. Investors should make decisions based on their own risk preferences and the original disclosures. Uncertainties remain regarding the transaction—please pay attention to related risks.
